Stay updated on BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer
Sign up to get notified when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.

Latest updates to the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page
- Check4 days agoChange DetectedRevision tag updated to v3.5.2 and the previous v3.5.0 tag was removed.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check39 days agoChange DetectedUpdated the page revision to v3.4.3; the previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.4.2 has been added and the prior 3.4.1 notice has been removed.SummaryDifference0.3%

- Check75 days agoChange DetectedA site-wide notice about a lapse in government funding was added, stating information may not be up-to-date and that operations may be affected, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check82 days agoChange DetectedThe page adds a glossary toggle and new metadata headers such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', with minor capitalization changes to labels like 'No FEAR Act Data'.SummaryDifference0.2%

Stay in the know with updates to BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer
Enter your email address, and we'll notify you when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.